Phosphodiesterase III inhibitors offer a new treatment for congestive cardiac failure by increasing intracellular calcium. While they improve hemodynamics and oxygen consumption, long-term survival benefits remain unknown.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science: